Keywords: Baxter International, Prism Pharma, M&A, Nexterone, Antiarrhythmic, Drug delivery

Baxter to acquire Prism Pharmaceuticals for up to $338 million

Article | 20 April 2011

Print This

With the aim of expanding its drug delivery offerings, USA-based drugs and medical device maker Baxter International (NYSE: BAX) says ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in